Global Immuno Oncology (I-O) Market: Trending in 2021
New York, NY 11 June 2021: The global immuno-oncology market size is expected to reach USD 38.89 billion by 2025 according to a new study by Polaris Market Research. The report “Immuno Oncology (I-O) Market Size, Trends, Industry Analysis By Treatment Approaches (Monoclonal Antibodies, Therapeutic Vaccines, Checkpoint Inhibitors, and Cytokines); By Novel Targets (IDO1i, LAG-3 CPI, oncolytic virus, STING agonist, TLR agonist, HDACi, TIL, VEGFi, MEKi, TIGIT, CPI, GITR agonist, TGF-b trap, and A2AR antagonist/CD73i); By Tumor Types; By Region: Market Size & Forecast, 2020 – 2026” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Immuno-oncology, also called as cancer immunotherapy is a biologic treatment, which enhances the body’s natural defenses to stop the growth of cancer. This therapy uses constituents made by the body or in a research laboratory to improve or reestablish the immune system function.
Immuno-oncology represents an innovative approach to cancer research that seeks to harness the body’s own immune system to fight tumor cells. Currently, world is at the forefront of this science with several compounds in development that are being investigated for use in a variety of cancers, as well as an approved immuno-oncology medicine that continues to be studied for new uses. The more precise targeting of patients for selected therapies is another important area of focus in oncology. Clinical biomarkers and pharmacogenomic studies are increasingly used to identify groups and sub-groups of patients most likely to benefit from an investigational agent in order to maximize its potential benefits.
The global immuno-oncology market is driven by the factors such as rising occurrence of different forms of cancer, technological advancements in the field of immune oncology for cancer treatment, and rising awareness concerning the benefits of ablation procedures over conventional treatment procedures. Moreover, rising number of ablation centers, surgical centers, and hospitals are driving the growth of tumor ablation market globally. Additionally, the developments in oncology treatments, leading to the increased development of pioneering products are also advancing towards significant growth of the global Immune Oncology market.
Request For Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/immuno-oncology-io-market/request-for-sample
The global immuno-oncology market size is expected to reach USD 38.89 billion by 2025 according to a new study by Polaris Market Research. The report “Immuno Oncology (I-O) Market Size, Trends, Industry Analysis By Treatment Approaches (Monoclonal Antibodies, Therapeutic Vaccines, Checkpoint Inhibitors, and Cytokines); By Novel Targets (IDO1i, LAG-3 CPI, oncolytic virus, STING agonist, TLR agonist, HDACi, TIL, VEGFi, MEKi, TIGIT, CPI, GITR agonist, TGF-b trap, and A2AR antagonist/CD73i); By Tumor Types; By Region: Market Size & Forecast, 2020 – 2026” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Immuno-oncology, also called as cancer immunotherapy is a biologic treatment, which enhances the body’s natural defenses to stop the growth of cancer. This therapy uses constituents made by the body or in a research laboratory to improve or reestablish the immune system function.
Immuno-oncology represents an innovative approach to cancer research that seeks to harness the body’s own immune system to fight tumor cells. Currently, world is at the forefront of this science with several compounds in development that are being investigated for use in a variety of cancers, as well as an approved immuno-oncology medicine that continues to be studied for new uses. The more precise targeting of patients for selected therapies is another important area of focus in oncology. Clinical biomarkers and pharmacogenomic studies are increasingly used to identify groups and sub-groups of patients most likely to benefit from an investigational agent in order to maximize its potential benefits.
The global immuno-oncology market is driven by the factors such as rising occurrence of different forms of cancer, technological advancements in the field of immune oncology for cancer treatment, and rising awareness concerning the benefits of ablation procedures over conventional treatment procedures. Moreover, rising number of ablation centers, surgical centers, and hospitals are driving the growth of tumor ablation market globally. Additionally, the developments in oncology treatments, leading to the increased development of pioneering products are also advancing towards significant growth of the global Immune Oncology market.
To get Incredible Discounts on this Premium Report, Click At: https://www.polarismarketresearch.com/industry-analysis/immuno-oncology-io-market/request-for-discount-pricing
Polaris Market research has segmented the Immuno-oncology market report on the basis of Treatment Approaches, novel targets, tumor types, and by region
Immuno-Oncology Treatment Approach Outlook (Revenue, USD Million, 2015 – 2025)
- Monoclonal Antibodies
- Therapeutic Vaccines
- Checkpoint Inhibitors
- Cytokines
Immuno-Oncology Novel Target Outlook (Revenue, USD Million, 2015 – 2025)
- IDO1i
- LAG-3 CPI
- Oncolytic virus
- STING agonist
- TLR agonist
- HDACi
- TIL
- VEGFi
- MEKi
- TIGIT
- CPI
- GITR agonist
- TGF-b trap
- A2AR antagonist/CD73i
Immuno-Oncology Tumor Type Outlook (Revenue, USD Million, 2015 – 2025)
- Melanoma
- Non-Small Cell Lung Cancer
- Renal Cell Carcinoma
- Head & Neck Cancer
- Bladder Cancer
- Classical Hodgkin’s Lymphoma
- Merkel Cell Carcinoma
- Others
Have Any Query or Specific Requirement? Request for customization: https://www.polarismarketresearch.com/industry-analysis/immuno-oncology-io-market/request-for-customization
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.
Contact Us:
Polaris Market Research
Phone: 1–646–568–9980
Email: [email protected]